Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ins degludec/liraglutide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Xultophy 100units/ml / 3.6mg/ml inj 3ml pre-filled pens
0601023AUBBAAAA
|
Xultophy | Ins degludec/liraglutide | Endocrine System | 5,044 |
|
Insulin degludec 100u/ml/Lirag 3.6mg/ml inj3ml pf dispos dev
0601023AUAAAAAA
|
Ins degludec/liraglutide | Ins degludec/liraglutide | Endocrine System | 360 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.